The Prevalence, Risk Factors and Optimal Biopsy Protocol of BE

Recruiting now · Not applicable

Conditions studied: Barrett's Esophagus, Intestinal Metaplasia

In brief

Detections of goblet cells and dysplasia are crucial for diagnosis and determining the surveillance program of Barrett's esophagus (BE). However, the optimal biopsy numbers and their yield rates of intestinal metaplasia (IM) and dysplasia are still uncertain, especially in Asia. The aim of this study was to determine the optimal biopsy protocol of BE.

Key facts

Study ID

NCT05818072

Run by

E-DA Hospital

People needed

165

Starts

2023-03-13

Expected to finish

2026-12-31

Last updated by the study team

2023-05-11

Who can join

Age: 20 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adults with columnar-lined esophagus

You may not qualify if…

• A prior history of endoscopic treatment for Barrett's Esophagus
• A prior history of upper gastrointestinal malignancy
• A prior history of total or subtotal gastrectomy
• Esophageal varices noted during the procedure
• Uncontrolled coagulopathy
• Taking antiplatelet drug or anticoagulant

Where it is running

• E-DA Hospital — Kaohsiung City, Taiwan (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.